These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Increased assessment and monitoring needed for patients receiving methadone. Merlo LJ; Gold MS Am J Med; 2008 May; 121(5):e23; author repply e25. PubMed ID: 18456018 [No Abstract] [Full Text] [Related]
43. Methadone: applied pharmacology and use as adjunctive treatment in chronic pain. Brown R; Kraus C; Fleming M; Reddy S Postgrad Med J; 2004 Nov; 80(949):654-9. PubMed ID: 15537850 [TBL] [Abstract][Full Text] [Related]
44. Opioid-sparing effect of diclofenac in cancer pain. Mercadante S; Sapio M; Caligara M; Serretta R; Dardanoni G; Barresi L J Pain Symptom Manage; 1997 Jul; 14(1):15-20. PubMed ID: 9223838 [TBL] [Abstract][Full Text] [Related]
45. Methadone:effective analgesia, confusion, and risk. Lipman AG J Pain Palliat Care Pharmacother; 2005; 19(2):3-5. PubMed ID: 16061455 [No Abstract] [Full Text] [Related]
46. Opioids in chronic non-malignant pain. Don't forget methadone for chronic pain. Byrne A BMJ; 2001 Sep; 323(7312):572. PubMed ID: 11573488 [No Abstract] [Full Text] [Related]
47. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain. Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307 [TBL] [Abstract][Full Text] [Related]
48. Scaling up methadone maintenance treatment for opioid-dependent prisoners in Iran. Farnia M; Ebrahimi B; Shams A; Zamani S Int J Drug Policy; 2010 Sep; 21(5):422-4. PubMed ID: 20413287 [TBL] [Abstract][Full Text] [Related]
49. Pain management in patients with advanced cancer. Berland D Ann Intern Med; 2000 Apr; 132(7):593. PubMed ID: 10744602 [No Abstract] [Full Text] [Related]
50. Methadone: a double edged sword. Lipman AG J Pain Palliat Care Pharmacother; 2005; 19(4):3-4. PubMed ID: 16431826 [No Abstract] [Full Text] [Related]
51. A formal feasibility study of sublingual methadone for breakthrough cancer pain. Hagen NA; Moulin DE; Brasher PM; Biondo PD; Eliasziw M; Watanabe SM; Stiles CR Palliat Med; 2010 Oct; 24(7):696-706. PubMed ID: 20671005 [TBL] [Abstract][Full Text] [Related]
52. Opioid rotation from methadone: fraught with difficulties. Bhimji K J Pain Symptom Manage; 2005 Apr; 29(4):334-5. PubMed ID: 15857735 [No Abstract] [Full Text] [Related]
53. Opioid rotation to methadone at home. Hernansanz S; Gutiérrez C; Rubiales AS; Flores LA; del Valle ML J Pain Symptom Manage; 2006 Jan; 31(1):2-4. PubMed ID: 16442475 [No Abstract] [Full Text] [Related]
54. [Treating hospitalized children in severe pain with oral methadone]. Shir Y; Shvelzon V; Rosen G Harefuah; 1998 Mar; 134(6):438-41, 503. PubMed ID: 10909571 [TBL] [Abstract][Full Text] [Related]
56. High dose levo-methadone treatment for cancer pain in a patient with a history of drug addiction. Ostgathe C; Gaertner J; Nauck F; Voltz R J Pain Symptom Manage; 2008 Mar; 35(3):229-31. PubMed ID: 18215496 [No Abstract] [Full Text] [Related]
57. The use of methadone "as needed", is it justified? Peppin JF J Opioid Manag; 2009; 5(1):7-9. PubMed ID: 19344042 [No Abstract] [Full Text] [Related]
58. A review of the use of methadone for the treatment of chronic noncancer pain. Lynch ME Pain Res Manag; 2005; 10(3):133-44. PubMed ID: 16175249 [TBL] [Abstract][Full Text] [Related]
59. The effect of age on opioid switching to methadone: a systematic review. Mercadante S; Bruera E J Palliat Med; 2012 Mar; 15(3):347-51. PubMed ID: 22352334 [TBL] [Abstract][Full Text] [Related]
60. Stop and go strategy for opioid switching requires flexibility. Mercadante S Eur J Cancer; 2012 Apr; 48(6):944-5; author reply 946-7. PubMed ID: 22305512 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]